Skip to main content

Table 3 Pathway analysis

From: Methylation and transcriptome analysis reveal lung adenocarcinoma-specific diagnostic biomarkers

ID Pathway Count P-value q-value
R-HSA-212436 Generic transcription pathway 15 0.000169248 0.01031453
WP3891 Benzene metabolism 2 0.000338181 0.01031453
R-HSA-73857 RNA polymerase II transcription 15 0.000564162 0.011471298
R-HSA-74160 Gene expression (transcription) 15 0.001668004 0.020896371
PA150642262 Platinum pathway, Pharmacokinetics/pharmacodynamics 2 0.001720726 0.020896371
R-HSA-156580 Phase II—conjugation of compounds 4 0.002055381 0.020896371
WP692 Sulfation biotransformation reaction 2 0.002963269 0.025340686
WP697 Estrogen metabolism 2 0.003323369 0.025340686
PWY-4061 Glutathione-mediated detoxification 2 0.005884846 0.035982304
R-HSA-156584 Cytosolic sulfonation of small molecules 2 0.006376838 0.035982304
path:hsa00983 Drug metabolism—other enzymes—Homo sapiens (human) 3 0.006488612 0.035982304
\